Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adaptor related protein complex 3 subunit mu 2 (AP3M2) is a medium subunit of the heterotetrameric adaptor protein complex 3 (AP-3), which is involved in the trafficking of proteins from the Golgi to lysosomes and specialized organelles, and plays a critical role in vesicle formation and cargo sorting.[1][2] In neurons, AP-3 containing AP3M2 is specifically implicated in the sorting and trafficking of synaptic vesicle proteins, with distinct isoforms mediating unique functions in neuronal physiology. AP3M2 deficiencies have been linked to various disorders, including some cancers and neurological diseases. There are no known drugs directly targeting AP3M2, but its status as a biomarker—especially in colorectal cancer—is under investigation.[7][1][2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adaptor related protein complex 3 subunit mu 2 (AP3M2).